Tony Robbins’ and Peter Diamandis’ longevity corporate Fountain Existence raises $18M by means of NewsFlicks

8 years in the past, orthopedic surgeon Dr. William Kapp attended a scientific convention that modified his skilled existence. 

He had long past from a non-public apply physician to co-founding an organization that constructed vital care hospitals to then promoting that corporate. It gave him an hobby for either side of healthcare: the drugs and industry aspects, he informed TechCrunch. 

So he went to the once a year convention hosted by means of famed physician-scientist Dr. Daniel Kraft to be told about new tech that might make stronger effects whilst reducing prices. Dr. Peter Diamandis, founder and chairman of the XPRIZE Basis, was once on degree that yr with Dr. Bob Hariri, a stem-cell pioneer and co-founder of a number of well being techs like genomics corporate, Human Longevity, Kapp mentioned. They mentioned genomics, microbiomics, and new tech that wasn’t a part of mainstream drugs.

Impressed, Kapp went again to his house the town of Naples, Florida, and “began a factor referred to as Longevity Efficiency Middle. The speculation was once to do early detection after which optimization of other people’s well being,” he mentioned.

In March 2020, Diamandis (pictured above) and his friend Tony Robbins heard of Kapp’s middle and visited. That they had a stem cellular startup referred to as Fountain Therapeutics. Dialog quickly became towards a merger, and by means of October that yr, the 2 firms changed into Fountain Existence.

Kapp remained CEO with each Diamandis and Robbins as his co-founders and board individuals.

As of late his board additionally comprises Hariri as an adviser; Todd Wanek, CEO of Ashley Furnishings Industries, as an investor; and rich Indian industry wealthy person B.Ok. Modi as an investor as smartly.

Fountain Existence tells TechCrunch solely that it simply raised an $18 million sequence B, led by means of EOS Ventures, with participation from lots of the current individuals of the board. Fountain prior to now raised an $80 million Sequence A and has raised about $108 million general, Kapp mentioned.

Longevity as an issue of great find out about by means of the scientific neighborhood is a brand new box. When Kapp (pictured beneath) first introduced his middle, “We didn’t know precisely what longevity intended,” he mentioned. However during the last 4 or 5 years, a lot more analysis has been completed. 

The primary theory of longevity, he mentioned, is “don’t die of the rest silly.” Subsequently, Fountain Existence’s facilities, of which there are 4 these days, have a heavy center of attention on prevention screening, on the lookout for diseases and persistent stipulations at their earliest phases after they have a tendency to be asymptomatic. Blood assessments and frame scans collect information on over 100 biomarkers from liver fats to “microbiome concentrations,” he mentioned.

The second one fundamental is optimization, that means bettering the ones markers with scientifically validated remedies, he mentioned. And the 3rd fundamental is “the use of the newest regenerative treatments below FDA trials,” to regard sickness or reach optimization.

Screening assessments might uncover, as an example, small intestinal bacterial overgrowth (SIBO), which, left untreated, might result in positive cancers, he mentioned. The answer, if stuck early, is to revive microbiome stability with particular, prescribed microbiotics.

For Fountain’s individuals, checking out is repeated each and every quarter or so, and sufferers can monitor effects and ask questions of an AI-powered app referred to as Zori.

However it’s expensive, Kapp admitted. A complete subscription prices $30,000 a yr, and $10,000 will duvet simply the checking out procedure and AI, however no longer ongoing assessments and scientific enhance.

Nonetheless, Kapp recollects two tales that informed him this paintings was once not off course. The spouse of a Robbins fan purchased a club for her husband, and the assessments stuck early-stage, asymptomatic kidney most cancers. The husband is now cancer-free. 

When international hotelier Sam Nazarian was once exploring a partnership with Fountain to put longevity facilities in luxurious motels, Nazarian did Fountain’s assessments and located a mind aneurysm. They effectively handled it, Nazarian has publicly mentioned. 

Kapp says the brand new investment will permit the corporate to open extra facilities. Along with Naples; Westchester, New York; Orlando; and Dallas, a middle in Houston will open in December. Facilities in Los Angeles and Miami are deliberate for Q2 of 2026. 

He hopes to unravel the affordability factor by means of running on “health center construction” the place Fountain trains scientific amenities on its methodologies. Kapp says that because the tech and experience turn out to be extra broadly to be had, this may pressure down prices for get admission to.

Fountain isn’t the one doctor-driven longevity checking out startup. Famed practical well being physician Mark Hyman has an organization referred to as Serve as Well being. It provides a package deal of about 160 blood assessments, with follow-up assessments each and every 3 to 6 months, for a $500/yr club (with further charges for added blood assessments). Its platform in a similar way analyzes and tracks take a look at effects, even supposing it doesn’t do complete frame scans or be offering direct get admission to to physicians.